{"disease":{"id":"oculomotor-dysfunction","name":"oculomotor dysfunction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03319966","title":"Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Hennepin Healthcare Research Institute","has_results":false},{"nct_id":"NCT06691646","title":"RECOGNeyes Gaze-Control Training","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"University of Nottingham","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}